Axcelis Technologies, Inc. (ACLS) – What Are Researchers Saying About This Stock?

Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) have received an average rating of “Hold” from the five analysts that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $148.67.

Several research firms recently weighed in on ACLS. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Friday, August 7th. Craig Hallum lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 target price for the company. in a research note on Friday, August 7th. Finally, Bank of America increased their target price on shares of Axcelis Technologies from $130.00 to $156.00 and gave the stock an “underperform” rating in a research report on Tuesday, June 23rd.

Axcelis Technologies Trading Up 0.9%

NASDAQ:ACLS opened at $134.71 on Monday. The stock has a market cap of $4.16 billion, a price-to-earnings ratio of 45.20, a price-to-earnings-growth ratio of 4.08 and a beta of 1.86. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.21 and a current ratio of 4.90. The business’s 50-day simple moving average is $125.08 and its 200 day simple moving average is $135.93. Axcelis Technologies has a one year low of $73.60 and a one year high of $193.78.

Axcelis Technologies (NASDAQ:ACLS) last posted its quarterly earnings data on Thursday, August 6th. The semiconductor company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.17. The firm had revenue of $215.18 million for the quarter, compared to the consensus estimate of $205.03 million. Axcelis Technologies had a net margin of 10.71% and a return on equity of 11.69%. The firm’s revenue was up 10.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.13 EPS. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. As a group, sell-side analysts predict that Axcelis Technologies will post 3.39 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Axcelis Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in ACLS. Reinhart Partners LLC. lifted its position in Axcelis Technologies by 14.2% during the 3rd quarter. Reinhart Partners LLC. now owns 1,060,636 shares of the semiconductor company’s stock worth $139,134,000 after buying an additional 131,976 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Axcelis Technologies by 0.4% during the first quarter. Dimensional Fund Advisors LP now owns 844,097 shares of the semiconductor company’s stock worth $78,565,000 after purchasing an additional 3,057 shares during the period. The Manufacturers Life Insurance Company lifted its stake in Axcelis Technologies by 3,402.5% in the first quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company’s stock valued at $45,772,000 after buying an additional 477,705 shares in the last quarter. Principal Financial Group Inc. increased its holdings in Axcelis Technologies by 5.1% during the 1st quarter. Principal Financial Group Inc. now owns 210,202 shares of the semiconductor company’s stock worth $19,566,000 after purchasing an additional 10,177 shares in the last quarter. Finally, Kennedy Capital Management LLC lifted its position in shares of Axcelis Technologies by 12.4% in the fourth quarter. Kennedy Capital Management LLC now owns 205,737 shares of the semiconductor company’s stock worth $16,529,000 after purchasing an additional 22,637 shares in the last quarter. 89.98% of the stock is owned by institutional investors.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc (NASDAQ: ACLS) develops and manufactures equipment used in semiconductor fabrication. The company’s primary business is ion implantation, a process that modifies the electrical properties of silicon and other semiconductor materials by introducing controlled amounts of dopants. Its systems are used by chip manufacturers to produce a range of semiconductor devices.

Axcelis offers the Purion family of ion implantation systems, including platforms designed for high-current, medium-current and high-energy applications.